Goldman Sachs Removed Charles River Labs (CRL) from its Conviction Sell List

Goldman Sachs removed Charles River Laboratories International Inc. (NYSE: CRL) from its Conviction Sell List. The firm is maintaining a Sell rating on the shares.

Charles River Laboratories International, Inc., together with its subsidiaries, provides solutions that advance the drug discovery and development process, including research models and associated services, and outsourced preclinical services worldwide.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Goldman Sachs Boosts Numbers on PVH Corp (PVH) After Q1 Beat
• Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
• Goldman Sachs Says Buy Shire plc (SHPGY) On Recent Weakness, Keeps Top Rating

Create E-mail Alert Related Categories

Analyst Comments

Related Entities

Goldman Sachs Conviction Sell List, Goldman Sachs

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter